NR3C1 and cancer: Our data showed that nuclear GR levels were significantly reduced under ciclesonide treatment (Figure 4F), and our immunofluorescence data showed that ciclesonide-treated cells showed lower levels of nuclear GR than untreated cancer cells (Figure 4G).